Anoctamin 6: Difference between revisions
CSV import |
CSV import |
||
| Line 23: | Line 23: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 04:07, 17 March 2025
Anoctamin 6 (ANO6), also known as TMEM16F, is a protein that in humans is encoded by the ANO6 gene. It is a member of the anoctamin family of proteins, which are known to be involved in various cellular functions such as chloride transport and phospholipid scrambling.
Function[edit]
ANO6 is a calcium-activated non-selective ion channel that mediates calcium dependent chloride flux across the cell membrane. It is also involved in the regulation of phospholipid scrambling, a process which exposes phosphatidylserine on the cell surface and plays a role in blood coagulation.
Clinical significance[edit]
Mutations in the ANO6 gene have been associated with Scott syndrome, a rare bleeding disorder characterized by impaired platelet function. Additionally, ANO6 has been implicated in the progression of certain types of cancer, including breast cancer and prostate cancer.
See also[edit]
References[edit]
<references />
